A Multi-Stakeholder Perspective on Adaptive Designs
Overview:
A full-day workshop at the University of Cambridge focused on ethical and methodological issues surrounding adaptive clinical trial designs. This event will bring together leading statisticians, ethicists, industry representatives, policymakers (including the World Health Organisation), regulators (including the Food and Drug Administration), and patient advocacy groups to discuss the evolving landscape of adaptive clinical trial designs and their ethical implications.
Speakers:
-
Frank Bretz (Novartis)
-
Rieke van der Graaf (University of Utrecht)
-
Thomas Jaki (MRC Biostatistics Unit)
-
Katherine Littler (World Health Organisation)
-
Alex John London (Carnegie Mellon University)
-
Richard Milne (University of Cambridge)
-
Philip Pallmann (University of Cardiff)
-
Mark Sheehan (Oxford Population Health)
-
Jerome Singh (University of KwaZulu-Natal)
-
Sofia S. Villar (MRC Biostatistics Unit)
-
Sue-Jane Wang (Food and Drug Administration)
-
Haiyan Zheng (University of Bath
Registration - £20 charge (N.B some student exemptions)
